Emerging Antiviral Takes Aim at COVID-19
As the COVID-19 pandemic shut down much of the world, George Painter's life geared up considerably. In a matter of weeks, Painter and his collaborators have seen the antiviral they were working onEIDD-2801go from a promising therapeutic for influenza to a potential weapon in the fight against COVID-19, the disease caused by the novel coronavirus.